Cargando…

Soluble ST2 suppresses the effect of interleukin-33 on lung type 2 innate lymphoid cells

Type 2 innate lymphoid cells (ILC2) in lungs produce interleukin (IL)-5 and IL-13 in response to IL-33 and may contribute to the development of allergic diseases such as asthma. However, little is known about negative regulators and effective inhibitors controlling ILC2 function. Here, we show that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayakawa, Hiroko, Hayakawa, Morisada, Tominaga, Shin-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600343/ https://www.ncbi.nlm.nih.gov/pubmed/28955848 http://dx.doi.org/10.1016/j.bbrep.2016.02.002

Ejemplares similares

Altered behavior in mice overexpressing soluble ST2
por: Kikuchi, Motoshi, et al.
Publicado: (2020)

Interleukin‐33 increases type 2 innate lymphoid cell count and their activation in eosinophilic asthma
por: Sun, Fengfei, et al.
Publicado: (2023)

Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
por: Iannazzo, Francesco, et al.
Publicado: (2022)

IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice
por: Li, Dong, et al.
Publicado: (2014)

Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022)

Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury
por: Chen, Wei-Yu, et al.
Publicado: (2020)

Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung
por: Faustino, Lucas D., et al.
Publicado: (2020)

STING activation in alveolar macrophages and group 2 innate lymphoid cells suppresses IL-33–driven type 2 immunopathology
por: She, Li, et al.
Publicado: (2021)

Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease
por: Kim, Dae-Jun, et al.
Publicado: (2013)

Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs
por: Watanabe, Masato, et al.
Publicado: (2022)

Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
por: McSorley, H J, et al.
Publicado: (2014)

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019)

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011)

Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome
por: Demyanets, Svitlana, et al.
Publicado: (2014)

IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis
por: Miller, Jessica E., et al.
Publicado: (2021)

Soluble form of the ST2 gene product exhibits growth promoting activity in NIH-3T3 cells
por: Tominaga, Shin-ichi, et al.
Publicado: (2015)

Interleukin-33 and Soluble ST2 as Potential Biomarkers of Cancer in Opium Users: A Nested Case-Control Study
por: Firouzabadi, Negar, et al.
Publicado: (2022)

Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2
por: Zhou, Lei, et al.
Publicado: (2019)

IL-33/ST2 axis in innate and acquired immunity to tumors
por: Jovanovic, Ivan P., et al.
Publicado: (2012)

IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing
por: Rak, Gregory D, et al.
Publicado: (2016)

IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow
por: Stier, Matthew T., et al.
Publicado: (2018)

Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis
por: Chen, Wei-Yu, et al.
Publicado: (2021)

A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
por: Salimi, Maryam, et al.
Publicado: (2013)

Genetic Association of Interleukin 33/ST2 Polymorphisms With Behcet’s Uveitis
por: Pei, Minghang, et al.
Publicado: (2021)

Eosinophils, but Not Type 2 Innate Lymphoid Cells, Are the Predominant Source of Interleukin 4 during the Innate Phase of Leishmania major Infection
por: Sasse, Carolin, et al.
Publicado: (2022)

Suppression of Immunotherapy on Group 2 Innate Lymphoid Cells in Allergic Rhinitis
por: Fan, Da-Chuan, et al.
Publicado: (2016)

Innate Immunity Modulation by the IL-33/ST2 System in Intestinal Mucosa
por: García-Miguel, Marina, et al.
Publicado: (2013)

Heterogeneity of type 2 innate lymphoid cells
por: Spits, Hergen, et al.
Publicado: (2022)

p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells
por: Petrova, Tsvetana, et al.
Publicado: (2020)

Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis
por: Chen, Lijie, et al.
Publicado: (2020)

Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study
por: Opinc, Aleksandra, et al.
Publicado: (2020)

Exploring the significance of interleukin-33/ST2 axis in minimal change disease
por: Kanazawa, Nobuhiro, et al.
Publicado: (2023)

Prostaglandin E(2) suppresses human group 2 innate lymphoid cell function
por: Maric, Jovana, et al.
Publicado: (2018)

Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy
por: Kieler, Markus, et al.
Publicado: (2018)

IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
por: Frisbee, Alyse L., et al.
Publicado: (2019)

Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33
por: Pfeffer, Paul E., et al.
Publicado: (2015)

IL-33 and Soluble ST2 Are Associated With Recurrent Spontaneous Abortion in Early Pregnancy
por: Zhao, Long, et al.
Publicado: (2022)

Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation
por: Mortaz, Esmaeil, et al.
Publicado: (2018)

Type 2 Innate Lymphoid Cells in Allergic Disease
por: Lund, Sean, et al.
Publicado: (2013)

Mesenchymal Stem Cells Suppress Severe Asthma by Directly Regulating Th2 Cells and Type 2 Innate Lymphoid Cells
por: Shin, Jae Woo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tsqd3n3gri8b70c52je4543s2h